Last reviewed · How we verify

Norethisterone acetate

Erasme University Hospital · FDA-approved active Small molecule ✓ Verified May 2026 Quality 5/100

Norethisterone acetate is a Small molecule drug developed by Erasme University Hospital. It is currently FDA-approved. Also known as: Primolut.

Norethisterone acetate is a small molecule progestin medication used in birth control pills, menopausal hormone therapy, and for the treatment of various gynecological disorders such as heavy menstrual bleeding and fibroid uterus. It is available in low-dose and high-dose formulations and can be used alone or in combination with an estrogen.

At a glance

Generic nameNorethisterone acetate
Also known asPrimolut
SponsorErasme University Hospital
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Norethisterone acetate

What is Norethisterone acetate?

Norethisterone acetate is a Small molecule drug developed by Erasme University Hospital.

Who makes Norethisterone acetate?

Norethisterone acetate is developed and marketed by Erasme University Hospital (see full Erasme University Hospital pipeline at /company/erasme-university-hospital).

Is Norethisterone acetate also known as anything else?

Norethisterone acetate is also known as Primolut.

What development phase is Norethisterone acetate in?

Norethisterone acetate is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing